NCT03749356 - Study to Evaluate the Efficacy and Safety of Once-Daily Tacrolimus in Kidney Transplant Recipients | Biotech Hunter

Enrollment

141

Participants

Timeline

Start Date

September 5, 2018

Primary Completion Date

July 30, 2020

Study Completion Date

December 4, 2020

Conditions

Kidney Transplant

Interventions

DRUG

TacroBell SR cap.

"* Orally, once-daily in the morning~* After first dose 0.2mg/kg, check the blood concentration of tacrolimus at each visit and adjust the dose to acheive the blood concentration maintaining at 3\~12ng/ml for 0 to 3months and then at 3\~8ng/ml for 3 to 6months of study treatment."

Trial Locations (1)

Unknown

Severance Hospital, Yonsei University Health System, Seoul